COVID-19 UPDATE: Firm Operations Continue Uninterrupted. Free Virtual Consultations Available. Click Here.
ACCIDENT NEWS

1 Injured in Crash at Interstate 10 and National Boulevard

Posted on by Staff Writer

Sedan, SUV Collide in Los Angeles Accident

Los Angeles, CA (May 19, 2020) – One person was injured in a crash in Los Angeles. The accident occurred on the morning of May 19 on Interstate 10. 

Two vehicles collided on Interstate 10 and National Boulevard. A driver in a Toyota Corolla was speeding and lost control. It then crashed into a Honda CRV. One person suffered serious injuries. 

#Los Angeles

#90064


March 9, 2020

1 Killed, 2 Injured in Crash on Highway 101 Near Interstate 880

4 Vehicles Involved in Fatal San Jose Accident...


September 3, 2020

1 Killed in Crash on U.S. 395 at Gill Station Coso Road

Vehicle Rolls Over in Fatal Olancha Accident...


June 9, 2020

Anthony Martinez Killed in Hit and Run Crash

Man Hit by Car in Fatal Laguna Hills Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


September 21, 2020

Lawsuit: ‘Tens Of Thousands’ Of Elmiron Patients At Risk For Vision Loss

A lawsuit filed on September 8 claims that “tens of thousands” of Elmiron patients were put at risk and hurt as a result of Janssen Pharmaceuticals’ conduct.


September 21, 2020

Lawsuit Claims Gilead Made ‘Unlawful’ Payment Over Truvada Competition

A lawsuit filed on Thursday claims that Gilead made an “unlawful” payment to Cipla in exchange for Cipla’s agreement to not compete against Truvada. The complaint states the payment “likely” came in the form of a license to produce Atripla, a license to produce Hepatitis C drugs in India or both.


READ MORE